CHEO Medical Staff Credentialing and Privileges

Please find below the current Corporate Medical Directives to agree to and Policies to be familiar with as part of the annual reappointment process.

Materials to review

Corporate Medical Directives

• 2039 – Corporate Antibiotic Resistant Organism (ARO) Admission Screening by Nurses Medical Directive

• 2051 – Corporate Topical Anesthetics for Procedural Pain Management Medical Directive 

• 2128 – Corporate Point of Care Testing (Glucose) for patients, staff, visitors at CHEO by RN, RPN and RRT 

• 2217 - Corporate Initiation and Administration of Nirsevimab by CHEO Nurses Medical Directive

• 2200 - Corporate Central Venous Access Management by VAT Medical Directive

• 2227 - Corporate Physician Assistant Medical Directive

Policies

• Acceptable Use of Information Systems Policy

• Completion of Records of Personal Health Information (PHI) Policy

• Conflict of Interest Policy

• Disclosure of Patient/Client Safety Events Policy

• Code of Conduct Policy

• CHEO Social Media Policy

• Violence in the Workplace Policy

• Workplace Conflict/Complaint Resolution Policy

• Workplace Harassment and Discrimination prevention Policy

• Professional Environment Policy

• Professional Dress and Accessories Policy

Medical Bylaws

• CHEO Medical by-laws